M. Chesi et al., FREQUENT DYSREGULATION OF THE C-MAF PROTOONCOGENE AT 16Q23 BY TRANSLOCATION TO AN IG LOCUS IN MULTIPLE-MYELOMA, Blood, 91(12), 1998, pp. 4457-4463
Dysregulation of oncogenes by translocation to an IgH (14q32) or IgL (
kappa, 2p11 or lambda, 22q11) locus is a frequent event in the pathoge
nesis of B-cell tumors. Translocations involving an IgH locus and a di
verse but nonrandom array of chromosomal loci occur in most multiple m
yeloma (MM) tumors even though the translocations often are not detect
ed by conventional cytogenetic analysis. In a continuing analysis of t
ranslocations in 21 MM lines, we show that the novel, karyotypically s
ilent t(14;16)(q32.3;q23) translocation is present in 5 MM lines, with
cloned breakpoints from 4 lines dispersed over an approximately 500-k
b region centromeric to the c-maf proto oncogene at 16q23. Another lin
e has a t(16;22)(q23;q11), with the breakpoint telomeric to c-maf, so
that the translocation breakpoints in these 6 lines bracket c-maf. Onl
y these 6 lines overexpress c-maf mRNA. As predicted for dysregulation
of c-maf by translocation, there is selective expression of one c-maf
allele in 2 informative lines with translocations. This is the first
human tumor in which the basic zipper c-maf transcription factor is sh
own to function as an oncogene.